Low apolipoprotein A-I level at intensive care unit admission and systemic inflammatory response syndrome exacerbation*

2004 ◽  
Vol 32 (3) ◽  
pp. 632-637 ◽  
Author(s):  
Catherine Chenaud ◽  
Paolo G. Merlani ◽  
Pascale Roux-Lombard ◽  
Danielle Burger ◽  
Stephan Harbarth ◽  
...  
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Systemic Inflammatory Response Syndrome ◽  
Inflammatory Response ◽  
Intensive Care Unit Admission ◽  
Systemic Inflammatory Response ◽  
Apolipoprotein A

Systemic Inflammatory Response Syndrome Score and Race As Predictors of Length of Stay in the Intensive Care Unit

2009 ◽  
Vol 18 (4) ◽  
pp. 339-346 ◽  
Author(s):  
E. G. NeSmith ◽  
S. P. Weinrich ◽  
J. O. Andrews ◽  
R. S. Medeiros ◽  
M. L. Hawkins ◽  
...  
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Length Of Stay ◽  
Systemic Inflammatory Response Syndrome ◽  
Inflammatory Response ◽  
Systemic Inflammatory Response

A 63-Year-Old Male with Severe Flaccid Weakness Post Motor Vehicle Accident

2016 ◽  
Author(s):  
Jeffrey A. Cohen ◽  
Justin J. Mowchun ◽  
Victoria H. Lawson ◽  
Nathaniel M. Robbins
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Systemic Inflammatory Response Syndrome ◽  
Inflammatory Response ◽  
Motor Vehicle ◽  
Motor Vehicle Accident ◽  
Neuromuscular Disorders ◽  
Specific Treatment ◽  
Systemic Inflammatory Response ◽  
High Dose

Neuromuscular disorders are important causes of newly acquired weakness in the intensive care unit. Although evaluation usually begins with physical examination findings, these can be compromised in the intensive care unit environment. Therefore, electrodiagnostic study becomes even more important as a tool in localizing weakness to nerve, muscle or neuromuscular junction. Critical illness neuropathy and myopathy occurs in the setting of sepsis and multiple organ failure where sepsis is accompanied by the systemic inflammatory response syndrome. Additional, intensive care unit-specific risk factors exist, predominantly relating to administration of high-dose steroids, nondepolarizing neuromuscular blocking agents, and sedating agents such as propofol. There is no specific treatment except for optimizing medical management of the underlying disorder, including prevention and management of sepsis, systemic inflammatory response syndrome, and organ damage, as well as avoidance of exacerbating medications.

Sign in / Sign up

Export Citation Format

Share Document